Results This assessment revealed a positive trend in the use of provider-administered and self-injection DMPA-SC from 2020 to 2023.
← all excerpts
Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment.
1
—
—